Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04666636 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mechanisms for Activation of Beige Adipose Tissue in Humans

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 25, 2026 to Jun 2027
    • Study completion pushed from Dec 1, 2026 to Dec 2027
    v9
  2. Site contact updatedv8
  3. Primary completion date: Jan 31, 2026 to Jun 25, 2026
    • Study completion date: Jan 31, 2026 to Dec 1, 2026
    v7
  4. Primary endpoints: 7 to 9
    • Interventions: Mirabegron (Drug), Placebo (Drug) to Mirabegron (Drug), Mirabegron 100 mg (Drug), Mirabegron 50 MG (Drug), Placebo (Drug)
    • Study arms: 2 to 4
    v6
  5. Primary and study completion dates: Dec 31, 2024 to Jan 31, 2026v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Collaborators expanded, about 10 wordsv3
  3. Study description expanded, about 5 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Philip Kern
3 trials monitored
See 2 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Mirabegron (Myrbetriq®, Astellas) is a highly specific and well-tolerated ß3 agonist marketed for overactive bladder. This trial will assess the effects of mirabegron on glucose tolerance and adipose tissue in prediabetic patients
Trial Details
NCT Number NCT04666636
Lead Sponsor Philip Kern
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 PreDiabetes
Related terms Diabetes Mellitus, Platelet Glycoprotein IV Deficiency, Prediabetic State
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov